Search
Investors
Careers
Investors
Careers
Company
Our Story
Leadership & Advisors
Pillar News
Distribution Partners
Strategic Partnership
Technology
Products
Portfolio Overview
IVD Products
Solid Tumor Tissue
Liquid Biopsy
Heme
BRCA, HRD, Methylation
InheritRevealâ„¢ Disease
Pharma
Resources
Resource Overview
Webinars and Presentations
Publications
Posters
Contact
Company
Our Story
Leadership & Advisors
Pillar News
Distribution Partners
Strategic Partnership
Technology
Products
Portfolio Overview
IVD Products
Solid Tumor Tissue
Liquid Biopsy
Heme
BRCA, HRD, Methylation
InheritRevealâ„¢ Disease
Pharma
Resources
Resource Overview
Webinars and Presentations
Publications
Posters
Contact
Company
Our Story
Leadership & Advisors
Pillar News
Distribution Partners
Strategic Partnership
Technology
Products
Portfolio Overview
IVD Products
Solid Tumor Tissue
Liquid Biopsy
Heme
BRCA, HRD, Methylation
Inherited Disease
Pharma
Resources
Resource Overview
Webinars and Presentations
Publications
Posters
Contact
Careers
Investors
Company
Our Story
Leadership & Advisors
Pillar News
Distribution Partners
Strategic Partnership
Technology
Products
Portfolio Overview
IVD Products
Solid Tumor Tissue
Liquid Biopsy
Heme
BRCA, HRD, Methylation
Inherited Disease
Pharma
Resources
Resource Overview
Webinars and Presentations
Publications
Posters
Contact
Careers
Investors
Publications
Abnormal TP53 Predicts Risk of Progression in Patients with Barrett’s Esophagus Regardless of a Diagnosis of Dysplasia
Publication Source:
Gastroenterology
TBC
Tags
Resource Topic
Heme